Johnson & Johnson introduces new intraocular lens TECNIS PureSee in India

Johnson & Johnson has announced the introduction of its TECNIS PureSee purely refractive intraocular lens (IOL) for individuals with presbyopia in India. 

“The TECNIS PureSee IOL features a purely refractive design that delivers uninterrupted, high-quality, vision with high best-in-category contrast and low-light performance, comparable to a monofocal IOL,” the company said in a statement.

“Cataract surgery is the most common surgery performed globally, with 28 million procedures each year. But only 10-15% of patients are getting advanced optical IOLs specifically designed for addressing issues of astigmatism and presbyopia, said Burzin Shahana, Country Manager, Surgical Vision India & South Asia, Johnson & Johnson MedTech.

“We are giving surgeons and a growing number of patients in India the choice of a premium IOL that combines clarity of vision and reduced visual symptoms,” he said. 

With its purely refractive design, the TECNIS PureSee IOL ensures surgeons’ ease of use in providing “high tolerance to refractive error,” the company said.

The product offers benefits, including perfect vision for increased spectacle independence, it added. 

A dysphotopsia profile that is comparable to monofocal IOL in frequency, bothersome and difficulty levels, which means little to no visual symptoms, such as halos, glares, and starbursts.

By 2050, the number of people aged over 60 years old is expected to more than double to 2.1 billion, and Asia Pacific will account for 65% of the global increase for this age group, the company said. 

Cataracts are the leading cause of treatable blindness in the world, it added.